EPS (Diluted) for Vertex Pharmaceuticals (VRTX)
According to Vertex Pharmaceuticals's latest reported financial statements, the company's current diluted EPS (TTM) is $15.33. Diluted earnings per share (EPS) is net income divided by the diluted weighted-average shares outstanding over the period. It expresses profit on a per-share basis — the figure investors use to value an individual share — and accounts for potential dilution from options, RSUs, and convertible securities.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingEPS (Diluted)Switch metric
TTM (last 4 quarters)
$15.33
YoY change
-836.5%
5Y CAGR
+8.3%
Peak year (2025)
$15.32
Latest annual
$15.32
EPS (Diluted) history chart for Vertex Pharmaceuticals (VRTX) from 1990 to 2025
EPS (Diluted) history table for Vertex Pharmaceuticals (VRTX) from 1990 to 2025
| Fiscal year | Period ended | Reported | EPS (Diluted) | YoY |
|---|---|---|---|---|
| 2025 | $15.32 | -836.5% | ||
| 2024 | $-2.08 | -115.0% | ||
| 2023 | $13.89 | +8.3% | ||
| 2022 | $12.82 | +42.3% | ||
| 2021 | $9.01 | -12.4% | ||
| 2020 | $10.29 | +128.2% | ||
| 2019 | $4.51 | -44.3% | ||
| 2018 | $8.09 | +677.9% | ||
| 2017 | $1.04 | -326.1% | ||
| 2016 | $-0.46 | -80.1% | ||
| 2015 | $-2.31 | -26.4% | ||
| 2014 | $-3.14 | +58.6% | ||
| 2013 | $-1.98 | +296.0% | ||
| 2012 | $-0.50 | -457.1% | ||
| 2011 | $0.14 | -103.7% | ||
| 2010 | $-3.77 | +1.9% | ||
| 2009 | $-3.70 | +13.1% | ||
| 2008 | $-3.27 | +7.9% | ||
| 2007 | $-3.03 | +65.6% | ||
| 2006 | $-1.83 | -19.7% | ||
| 2005 | $-2.28 | +7.5% | ||
| 2004 | $-2.12 | -17.2% | ||
| 2003 | $-2.56 | +79.0% | ||
| 2002 | $-1.43 | +60.7% | ||
| 2001 | $-0.89 | +50.8% | ||
| 2000 | $-0.59 | -26.3% | ||
| 1999 | $-0.80 | +23.1% | ||
| 1998 | $-0.65 | +58.5% | ||
| 1997 | $-0.41 | -61.7% | ||
| 1996 | $-1.07 | +69.8% | ||
| 1995 | $-0.63 | +12.5% | ||
| 1994 | $-0.56 | -800.0% | ||
| 1993 | $0.08 | -122.9% | ||
| 1992 | $-0.35 | 0.0% | ||
| 1991 | $-0.35 | +59.1% | ||
| 1990 | $-0.22 | — |
EPS (Diluted) values are taken from Vertex Pharmaceuticals's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
2025's annual diluted EPS for Vertex Pharmaceuticals (VRTX) came in at $15.32 – plunged 836.5% year-over-year.
Looking at the 2020–2025 (5 years) stretch, Vertex Pharmaceuticals diluted EPS compounded at +8.3% per year, with the latest reading among the more recent periods of the dataset.
Across the available history, diluted EPS reached its high of $15.32 in 2025 and its low of $-3.77 in 2010.
Vertex Pharmaceuticals (VRTX) sits 3rd of 8 Healthcare peers we track on this metric, against a peer median of $13.16.
Vertex Pharmaceuticals EPS (Diluted) by Year
Vertex Pharmaceuticals EPS (Diluted) 2025: $15.32
Vertex Pharmaceuticals diluted EPS in 2025 was $15.32, plunged 836.5% below 2024. This figure represents the highest annual value in the available history.
Vertex Pharmaceuticals EPS (Diluted) 2024: $-2.08
Vertex Pharmaceuticals diluted EPS in 2024 was $-2.08, plunged 115.0% below 2023.
Vertex Pharmaceuticals EPS (Diluted) 2023: $13.89
Vertex Pharmaceuticals diluted EPS in 2023 was $13.89, grew 8.3% from 2022.
Vertex Pharmaceuticals EPS (Diluted) 2022: $12.82
Vertex Pharmaceuticals diluted EPS in 2022 was $12.82, surged 42.3% from 2021.
Vertex Pharmaceuticals EPS (Diluted) 2021: $9.01
Vertex Pharmaceuticals diluted EPS in 2021 was $9.01.
See more financial history for Vertex Pharmaceuticals (VRTX).
Sector peers — EPS (Diluted)
Companies in the same sector as Vertex Pharmaceuticals, ranked by their latest diluted EPS.
| Company | EPS (Diluted) | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $23.03 | Healthcare |
| Eli Lilly and Company (LLY) | $22.95 | Healthcare |
| Amgen Inc. (AMGN) | $14.23 | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $13.23 | Healthcare |
| AstraZeneca PLC (AZN) | $13.08 | Healthcare |
| Johnson & Johnson (JNJ) | $11.03 | Healthcare |
| Merck & Co., Inc. (MRK) | $7.28 | Healthcare |
| AbbVie Inc. (ABBV) | $2.37 | Healthcare |
Frequently asked questions
What is Vertex Pharmaceuticals's diluted EPS?
- Latest reported diluted EPS for Vertex Pharmaceuticals (VRTX) is $15.33 (period ending December 31, 2025).
How has Vertex Pharmaceuticals diluted EPS changed year-over-year?
- Vertex Pharmaceuticals (VRTX) diluted EPS changed -836.5% year-over-year on the latest annual filing.
What is the long-term growth rate of Vertex Pharmaceuticals diluted EPS?
- Vertex Pharmaceuticals (VRTX) diluted EPS compound annual growth rate is +8.3% over the most recent 5 years available.
When did Vertex Pharmaceuticals diluted EPS hit its highest annual value?
- Vertex Pharmaceuticals diluted EPS reached its highest annual value of $15.32 in 2025.
What was Vertex Pharmaceuticals diluted EPS in 2024?
- Vertex Pharmaceuticals (VRTX) diluted EPS in 2024 was $-2.08.
What was Vertex Pharmaceuticals diluted EPS in 2025?
- Vertex Pharmaceuticals (VRTX) diluted EPS in 2025 was $15.32.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
VRTX Overview
Company profile, financial tools, and key metrics
VRTX Revenue Counter
Earns $381.74 every second. See per minute, hour, and day.
VRTX Earnings Counter
Earns $125.36 per second net profit. See per minute, hour, and day.
VRTX Economic Scale
Exceeds Somalia, Fed. Rep.'s GDP. Compare with world economies.
VRTX What If Invested
What if you had invested $1,000? See historical returns from any date.
VRTX How It Makes Money
Discover visual breakdown of $12.04B in revenue — where it comes from and where it goes.
VRTX Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
VRTX Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
VRTX Daily Price Character
Explosive · 48.3% historical win rate (green days). Streaks & record days.
VRTX Buybacks
1.75% TTM buyback yield. Shareholder yield & SBC comparison.
VRTX Stock Split History
1 split on record. Dates, ratios, and cumulative multiple.